Summary

Common medications used to treat anemia may also slow down cancer cell growth, according to new research from Finland. Researchers from the University of Oulu and the University of Eastern Finland discovered that these drugs affect cell metabolism and growth in ways previously unknown. The findings, published in Redox Biology , suggest that the drugs could benefit cancer patients who often suffer from anemia, potentially treating two problems at once. The medications, known as HIF-PHIs, are currently used to help patients with chronic kidney disease produce more red blood cells.

AI summaries can be wrong sometimes—always verify important details using the source article.